All News about MoonLake Immunotherapeutics - Class A Ordinary Shares![]() Via Benzinga
![]() ![]() ![]()
What 10 Analyst Ratings Have To Say About MoonLake
May 01, 2023
Via Benzinga
![]()
Where MoonLake Stands With Analysts
March 20, 2023
Via Benzinga
![]()
FDA Clears MoonLake's Nanobody Study For Arthritis Patients
September 26, 2022
Via Benzinga
![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
February 14, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022
November 11, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|